Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.6.4 (
chondroitinase
)
2,039
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report further characterization of a cementum-derived protein that promotes the adhesion and spreading of periodontal cells. The
cementum attachment protein
(
CAP
) was extracted from bovine cementum, separated by diethylamino ethyl (DEAE)-cellulose chromatography, and purified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and C18 reverse phase high performance liquid chromatography. The purified preparation contained a single protein band migrating with M(r) 56,000. It did not cross-react with polyclonal antibodies to osteopontin, vitronectin, or other attachment proteins. The attachment activity was resistant to
chondroitinase
ABC digestion. An internal amino acid sequence of six peptides was determined by microsequencing, and the peptide sequences were not present in other attachment proteins described in cementum. Four sequences contained Gly-X-Y repeats typical of collagen helix. One 17 amino acid peptide had 82% homology with a type XII collagen domain. However, bovine type XII collagen did not promote fibroblast attachment. Although another 19-amino-acid-long peptide had 95% homology to bovine alpha 1 [I], two other peptides were only 74% and 68% homologous, and the
CAP
was not recognized by anti-type I collagen antibody. The attachment activity of
CAP
was susceptible to bacterial collagenase. The
CAP
did not cross-react with antibodies to type V, XII, and XIV collagens. These data and our previous immunostaining data indicate that the
CAP
is not related to other collagens or attachment proteins and that it is a collagenous attachment protein localized in cementum.
...
PMID:Characterization of a collagenous cementum-derived attachment protein. 915 84